Home » Topics » Hematologic, BioWorld Science

Hematologic, BioWorld Science
RSS

Fibrinogen receptor antagonists under development at E. Merck

Jan. 10, 1997

Thrombin-binding anticoagulant disclosed by Japanese scientists

Jan. 10, 1997

Boehringer Mannheim clot-busting drug introduced in first market

Jan. 7, 1997

Thrombolytic agent introduced in Germany

Dec. 31, 1996

BMS describes thrombin-activatable plasminogen activator

Dec. 31, 1996

Novel thrombin inhibitors in development at LG Chemical

Dec. 31, 1996

Fujisawa discloses antiplatelet agents

Dec. 24, 1996

New antiplatelet drugs from Takeda

Dec. 23, 1996

New antithrombotic agents described by Pfizer

Dec. 23, 1996

Corvas and Schering-Plough expand antithrombotic collaboration

Dec. 18, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 10, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...